In this issue:
Ruxolitinib for hydroxycarbamide-resistant/-intolerant polycythaemia vera
Encapsulated cytarabinedaunorubicin in higher-risk MDS/CMML
Mental health disorders impact survival in older patients with DLBCL
Statin use and MPN risk
Economic burden of SCD in Sweden
Isatuximab + bortezomib-lenalidomide-dexamethasone in newly diagnosed myeloma
Fatigue and health-related QOL in PNH
Health-related QOL in β-thalassaemia
Sequence of TBI-based myeloablative conditioning
Milademetan + low-dose cytarabine ± venetoclax in AML
Please login below to download this issue (PDF)